NEW YORK ( TheStreet) -- DexCom (Nasdaq: DXCM) hit a new 52-week low Monday as it is currently trading at $6.87, below its previous 52-week low of $6.90 with 50,212 shares traded as of 10:09 a.m. ET. Average volume has been 658,800 shares over the past 30 days.

DexCom has a market cap of $472.6 million and is part of the health care sector and health services industry. Shares are down 48% year to date as of the close of trading on Friday.

DexCom, Inc., a medical device company, engages in the design, development, and commercialization of continuous glucose monitoring systems for people with diabetes in the United States.

TheStreet Ratings rates DexCom as a sell. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself. You can view the full DexCom Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.

If you liked this article you might like

Apple Watch Is on Its Way to Becoming a $6 Billion Business, but Is That Really Enough?

DexCom Shares Rise After FDA Approves G5 Mobile App for Android Devices

Apple Watch Appears on Its Way to Becoming a $6 Billion Business

DexCom Stock Surging on Apple Watch Partnership

Markets Down? Get Used to It: Cramer's 'Mad Money' Recap (Wednesday 5/17/17)